Baloxavir Marboxil is a novel antiviral prodrug used for the treatment of acute uncomplicated influenza. It is a selective inhibitor of the cap-dependent endonuclease essential for viral mRNA transcription, making it effective against both influenza A and B viruses.
Our Baloxavir Marboxil API is produced under strict GMP standards, ensuring high purity and stability. It is suitable for further formulation development in oral dosage forms for antiviral therapies.
Applications:
Active ingredient for influenza antiviral drugs
R&D and pharmaceutical formulation use
Combination therapies for flu virus control
Packaging:
1g, 10g, 100g, 1kg aluminum foil bags or as customer request
Storage:
Store in a tightly sealed container at 2–8°C, protected from light and moisture.
![5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate](http://iprorwxhiprnlk5q.ldycdn.com/cloud/lnBpmKmmllSRpklminqjjm/5-2R-2-Aminopropyl-1-3-benzoyloxy-propyl-2-3-dihydro1H-indole-7-carbonitrile-2R-3R-2-3-dihydroxybuta-640-640.jpg)
